Katharina A Schindlbeck1, Janek Becker2, Felix Berger2, Arne Mehl3, Charlotte Rewitzer3, Sarah Geffe3, Peter M Koch3, Jan C Preiß2, Britta Siegmund2, Jochen Maul2,4, Frank Marzinzik3. 1. Department of Neurology, Charité-Universitätsmedizin Berlin, Hindenburgdamm 30, 12200, Berlin, Germany. KSchindl@northwell.edu. 2. Department of Medicine I (Gastroenterology, Infectious Diseases, Rheumatology), Charité-Universitätsmedizin Berlin, Berlin, Germany. 3. Department of Neurology, Charité-Universitätsmedizin Berlin, Hindenburgdamm 30, 12200, Berlin, Germany. 4. Gastroenterologie am Bayerischen Platz, Berlin, Germany.
Abstract
PURPOSE: Inflammatory bowel disease has been associated with neurological symptoms including restless legs syndrome. Here, we investigated the impact of restless legs syndrome in patients with inflammatory bowel disease on sleep, fatigue, mood, cognition, and quality of life. METHODS: Two groups of inflammatory bowel disease patients, with and without restless legs syndrome, were prospectively evaluated for sleep disorders, fatigue, daytime sleepiness, depression, anxiety, and health-related quality of life. Furthermore, global cognitive function, executive function, attention, and concentration were assessed in both groups. Disease activity and duration of inflammatory bowel disease as well as current medication were assessed by interview. Inflammatory bowel disease patients with and without restless legs syndrome were matched for age, education, severity, and duration of their inflammatory bowel disease. RESULTS: Patients with inflammatory bowel disease and clinically relevant restless leg syndrome suffered significantly more frequent from sleep disturbances including sleep latency and duration, more fatigue, and worse health-related quality of life as compared to inflammatory bowel disease patients without restless legs syndrome. Affect and cognitive function including cognitive flexibility, attention, and concentration showed no significant differences among groups, indicating to be not related to restless legs syndrome. CONCLUSIONS: Sleep disorders including longer sleep latency, shorter sleep duration, and fatigue are characteristic symptoms of restless legs syndrome in inflammatory bowel disease patients, resulting in worse health-related quality of life. Therefore, clinicians treating patients with inflammatory bowel disease should be alert for restless legs syndrome.
PURPOSE:Inflammatory bowel disease has been associated with neurological symptoms including restless legs syndrome. Here, we investigated the impact of restless legs syndrome in patients with inflammatory bowel disease on sleep, fatigue, mood, cognition, and quality of life. METHODS: Two groups of inflammatory bowel diseasepatients, with and without restless legs syndrome, were prospectively evaluated for sleep disorders, fatigue, daytime sleepiness, depression, anxiety, and health-related quality of life. Furthermore, global cognitive function, executive function, attention, and concentration were assessed in both groups. Disease activity and duration of inflammatory bowel disease as well as current medication were assessed by interview. Inflammatory bowel diseasepatients with and without restless legs syndrome were matched for age, education, severity, and duration of their inflammatory bowel disease. RESULTS:Patients with inflammatory bowel disease and clinically relevant restless leg syndrome suffered significantly more frequent from sleep disturbances including sleep latency and duration, more fatigue, and worse health-related quality of life as compared to inflammatory bowel diseasepatients without restless legs syndrome. Affect and cognitive function including cognitive flexibility, attention, and concentration showed no significant differences among groups, indicating to be not related to restless legs syndrome. CONCLUSIONS:Sleep disorders including longer sleep latency, shorter sleep duration, and fatigue are characteristic symptoms of restless legs syndrome in inflammatory bowel diseasepatients, resulting in worse health-related quality of life. Therefore, clinicians treating patients with inflammatory bowel disease should be alert for restless legs syndrome.
Entities:
Keywords:
Inflammatory bowel disease; Quality of life; Restless legs syndrome
Authors: Lesley A Graff; Norah Vincent; John R Walker; Ian Clara; Rachel Carr; Jason Ediger; Norine Miller; Linda Rogala; Patricia Rawsthorne; Lisa Lix; Charles N Bernstein Journal: Inflamm Bowel Dis Date: 2010-12-22 Impact factor: 5.325
Authors: Richard P Allen; Daniel L Picchietti; Diego Garcia-Borreguero; William G Ondo; Arthur S Walters; John W Winkelman; Marco Zucconi; Raffaele Ferri; Claudia Trenkwalder; Hochang B Lee Journal: Sleep Med Date: 2014-05-17 Impact factor: 3.492
Authors: Stephany Fulda; Marie E Beitinger; Simone Reppermund; Juliane Winkelmann; Thomas C Wetter Journal: Mov Disord Date: 2010-11-15 Impact factor: 10.338
Authors: Robin G Wilson; Betsy W Stevens; Abra Y Guo; Caitlin N Russell; Anna Thornton; Melissa A Cohen; Holly C Sturgeon; Cosmas Giallourakis; Hamed Khalili; Deanna D Nguyen; Vijay Yajnik; Jenny Sauk; Ashwin N Ananthakrishnan Journal: Dig Dis Sci Date: 2015-02-21 Impact factor: 3.199
Authors: James D Lewis; Shaokun Chuai; Lisa Nessel; Gary R Lichtenstein; Faten N Aberra; Jonas H Ellenberg Journal: Inflamm Bowel Dis Date: 2008-12 Impact factor: 5.325
Authors: Janek Becker; Felix Berger; Katharina A Schindlbeck; Denis Poddubnyy; Peter M Koch; Jan C Preiß; Britta Siegmund; Frank Marzinzik; Jochen Maul Journal: Int J Colorectal Dis Date: 2018-04-03 Impact factor: 2.571
Authors: Chaowapong Jarasvaraparn; Kimberly Zlomke; Noelle C Vann; Bin Wang; Karen D Crissinger; David A Gremse Journal: Ann Gastroenterol Dig Disord Date: 2018-12-31
Authors: Othman R AlHarbi; Ahmad Bahammam; Awad H Olaish; Nahla A Azzam; Abdulrahman A Aljebreen; Majid A Almadi; Suhail A Alsaleh Journal: Saudi J Gastroenterol Date: 2021 Nov-Dec Impact factor: 2.485